Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irfan Nuhoglu

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Revista Da Associacao Medica Brasileira (1992)|July 19, 2023
Comparison of orlistat and orlistat plus metformin therapy between diabetic and nondiabetic groupsYasemin Emur Gunay, Savaş Volkan Kişioğlu, Serdar Karakullukçu, et al.
Obesity Facts|June 29, 2025
Impact of Obesity on Metabolic Control in Type 2 Diabetes: Five-Year Trends of Turkish Nationwide Survey of Glycemic and Other Metabolic Parameters of Patients with Diabetes (TEMD Obesity Study, 2017-2022)Sinem Kiyici, Ibrahim Demirci, Alper Sonmez, et al.
Archives of Medical Sciences. Atherosclerotic Diseases|May 24, 2021
Clinical research of insulin glargine U300 in type 1 diabetes mellitus patients with frequent hypoglycaemia: real-world experienceSavaş Volkan Kişioğlu, Ahmet Suat Demir, Damla Tufekci, et al.
International Journal of Clinical Practice|May 18, 2021
Clinical research of insulin glargine U300 basal-bolus therapy and insulin degludec/aspart co-formulation in type 2 diabetes mellitus: A real world experienceSavas Volkan Kisioglu, Ahmet Suat Demir, Damla Tufekci, et al.
Endocrine|July 14, 2023
Can signal peptide-CUB-EGF domain-containing protein 1 (SCUBE-1) be used as an indicator of endothelial dysfunction in acromegaly patients?Damla Tufekci, Irfan Nuhoglu, Sumeyye Sura Ayan, et al.
Diabetes Research and Clinical Practice|November 26, 2020
Patterns and preferences of antidiabetic drug use in Turkish patients with type 2 diabetes - A nationwide cross-sectional study (TEMD treatment study)Cem Haymana, Alper Sonmez, Ibrahim Demirci, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Revista Da Associacao Medica Brasileira (1992)|July 19, 2023
Comparison of orlistat and orlistat plus metformin therapy between diabetic and nondiabetic groupsYasemin Emur Gunay, Savaş Volkan Kişioğlu, Serdar Karakullukçu, et al.
Obesity Facts|June 29, 2025
Impact of Obesity on Metabolic Control in Type 2 Diabetes: Five-Year Trends of Turkish Nationwide Survey of Glycemic and Other Metabolic Parameters of Patients with Diabetes (TEMD Obesity Study, 2017-2022)Sinem Kiyici, Ibrahim Demirci, Alper Sonmez, et al.
Archives of Medical Sciences. Atherosclerotic Diseases|May 24, 2021
Clinical research of insulin glargine U300 in type 1 diabetes mellitus patients with frequent hypoglycaemia: real-world experienceSavaş Volkan Kişioğlu, Ahmet Suat Demir, Damla Tufekci, et al.
International Journal of Clinical Practice|May 18, 2021
Clinical research of insulin glargine U300 basal-bolus therapy and insulin degludec/aspart co-formulation in type 2 diabetes mellitus: A real world experienceSavas Volkan Kisioglu, Ahmet Suat Demir, Damla Tufekci, et al.
Endocrine|July 14, 2023
Can signal peptide-CUB-EGF domain-containing protein 1 (SCUBE-1) be used as an indicator of endothelial dysfunction in acromegaly patients?Damla Tufekci, Irfan Nuhoglu, Sumeyye Sura Ayan, et al.
Diabetes Research and Clinical Practice|November 26, 2020
Patterns and preferences of antidiabetic drug use in Turkish patients with type 2 diabetes - A nationwide cross-sectional study (TEMD treatment study)Cem Haymana, Alper Sonmez, Ibrahim Demirci, et al.
Pageof 3